AbbVie | ABBV - Выручка от реализации

Биржевая цена
208.09
Изменение за день
-3.23 -1.53%
Ежемесячно
-0.36%
Ежегодный
4.85%
Q2 прогноз
194.46




Продажи Изменить Дата
AbbVie USD 15B 1.62B 2026-03
Abbott USD 11.16B 300M 2026-03
ALKERMES USD 384.5M 9.7M 2025-12
Amgen USD 8.62B 1.28B 2026-03
AstraZeneca USD 15.29B 213M 2026-03
Biogen USD 2.25B 30M 2026-03
BioMarin Pharmaceutical USD 875M 99M 2025-12
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Coherus Biosciences USD 12.75M 1.18M 2025-12
Eisai JPY 219.94B 22.58B 2025-12
Eli Lilly USD 19.8B 500M 2026-03
Gilead Sciences USD 7.93B 130M 2025-12
GlaxoSmithKline GBP 7.63B 991M 2026-03
Infinity Pharmaceuticals USD 583K 148K 2023-06
J&J USD 24.1B 500M 2026-03
Medtronic USD 9B 39M 2026-01
Merck USD 16.29B 110M 2026-03
Neurocrine Biosciences USD 805.5M 10.6M 2025-12
Novartis USD 13.11B 226M 2026-03
Pacira USD 177M 19.87M 2026-03
Perrigo USD 1.11B 70M 2025-12
Pfizer USD 17.58B 880M 2025-12
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.24B 60M 2026-03
UCB EUR 4.25B 764M 2025-12
Ultragenyx Pharmaceutical USD 207M 47M 2025-12
United Therapeutics USD 790.2M 9.3M 2025-12
Vertex Pharmaceuticals USD 3.19B 110M 2025-12
Zoetis USD 2.4B 0 2025-12